JP2014516360A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014516360A5 JP2014516360A5 JP2014505570A JP2014505570A JP2014516360A5 JP 2014516360 A5 JP2014516360 A5 JP 2014516360A5 JP 2014505570 A JP2014505570 A JP 2014505570A JP 2014505570 A JP2014505570 A JP 2014505570A JP 2014516360 A5 JP2014516360 A5 JP 2014516360A5
- Authority
- JP
- Japan
- Prior art keywords
- pyrrole
- carboxamide
- aminopyrimidin
- chloro
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 21
- 229910052739 hydrogen Inorganic materials 0.000 claims 17
- 239000001257 hydrogen Substances 0.000 claims 17
- 125000000623 heterocyclic group Chemical group 0.000 claims 12
- 150000003839 salts Chemical class 0.000 claims 12
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 9
- 125000000217 alkyl group Chemical group 0.000 claims 8
- 125000003118 aryl group Chemical group 0.000 claims 6
- 125000000753 cycloalkyl group Chemical group 0.000 claims 6
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 5
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 5
- 125000003710 aryl alkyl group Chemical group 0.000 claims 5
- 150000002431 hydrogen Chemical class 0.000 claims 5
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims 4
- -1 linear or branched Chemical group 0.000 claims 4
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 claims 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims 3
- 238000006243 chemical reaction Methods 0.000 claims 3
- 125000004093 cyano group Chemical group *C#N 0.000 claims 3
- 125000005842 heteroatom Chemical group 0.000 claims 3
- 229910052757 nitrogen Inorganic materials 0.000 claims 3
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 3
- 229910052760 oxygen Inorganic materials 0.000 claims 3
- 229910052717 sulfur Inorganic materials 0.000 claims 3
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 2
- DQDASFFHMDSYAZ-UHFFFAOYSA-N 5-(2-aminopyrimidin-4-yl)-2-(5-chloro-2-methylphenyl)-1h-pyrrole-3-carboxamide Chemical compound CC1=CC=C(Cl)C=C1C1=C(C(N)=O)C=C(C=2N=C(N)N=CC=2)N1 DQDASFFHMDSYAZ-UHFFFAOYSA-N 0.000 claims 2
- 101001043818 Mus musculus Interleukin-31 receptor subunit alpha Proteins 0.000 claims 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 claims 2
- 230000002378 acidificating effect Effects 0.000 claims 2
- 230000009435 amidation Effects 0.000 claims 2
- 238000007112 amidation reaction Methods 0.000 claims 2
- 239000002246 antineoplastic agent Substances 0.000 claims 2
- 150000001733 carboxylic acid esters Chemical class 0.000 claims 2
- 229910052801 chlorine Inorganic materials 0.000 claims 2
- 239000000460 chlorine Substances 0.000 claims 2
- 125000001309 chloro group Chemical group Cl* 0.000 claims 2
- 238000005859 coupling reaction Methods 0.000 claims 2
- 229940127089 cytotoxic agent Drugs 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 125000005843 halogen group Chemical group 0.000 claims 2
- 230000007062 hydrolysis Effects 0.000 claims 2
- 238000006460 hydrolysis reaction Methods 0.000 claims 2
- 230000003301 hydrolyzing effect Effects 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- YPBDHHDMOYAYHZ-UHFFFAOYSA-N 2-(5-chloro-2-methylphenyl)-5-(2-methylpyrimidin-4-yl)-1h-pyrrole-3-carboxamide Chemical compound CC1=NC=CC(C=2NC(=C(C(N)=O)C=2)C=2C(=CC=C(Cl)C=2)C)=N1 YPBDHHDMOYAYHZ-UHFFFAOYSA-N 0.000 claims 1
- AOUBZGNTXINLBC-UHFFFAOYSA-N 2-(5-chloro-2-methylphenyl)-5-pyrimidin-4-yl-1h-pyrrole-3-carboxamide Chemical compound CC1=CC=C(Cl)C=C1C1=C(C(N)=O)C=C(C=2N=CN=CC=2)N1 AOUBZGNTXINLBC-UHFFFAOYSA-N 0.000 claims 1
- MIEONHFLSVAHFB-UHFFFAOYSA-N 5-(2-aminopyrimidin-4-yl)-2-(2,5-dichlorophenyl)-1h-pyrrole-3-carboxamide Chemical compound NC(=O)C=1C=C(C=2N=C(N)N=CC=2)NC=1C1=CC(Cl)=CC=C1Cl MIEONHFLSVAHFB-UHFFFAOYSA-N 0.000 claims 1
- NEBCQIBCTNRMAZ-UHFFFAOYSA-N 5-(2-aminopyrimidin-4-yl)-2-(2,5-difluorophenyl)-1h-pyrrole-3-carboxamide Chemical compound NC(=O)C=1C=C(C=2N=C(N)N=CC=2)NC=1C1=CC(F)=CC=C1F NEBCQIBCTNRMAZ-UHFFFAOYSA-N 0.000 claims 1
- NHJGPIPPXVFNFE-UHFFFAOYSA-N 5-(2-aminopyrimidin-4-yl)-2-(2,5-dimethylphenyl)-1h-pyrrole-3-carboxamide Chemical compound CC1=CC=C(C)C(C2=C(C=C(N2)C=2N=C(N)N=CC=2)C(N)=O)=C1 NHJGPIPPXVFNFE-UHFFFAOYSA-N 0.000 claims 1
- OVEPNDUIJPTNEM-UHFFFAOYSA-N 5-(2-aminopyrimidin-4-yl)-2-(2-chloro-5-cyanophenyl)-1h-pyrrole-3-carboxamide Chemical compound NC(=O)C=1C=C(C=2N=C(N)N=CC=2)NC=1C1=CC(C#N)=CC=C1Cl OVEPNDUIJPTNEM-UHFFFAOYSA-N 0.000 claims 1
- WIVPUMFEYLUDQN-UHFFFAOYSA-N 5-(2-aminopyrimidin-4-yl)-2-(2-chloro-5-ethylphenyl)-1h-pyrrole-3-carboxamide Chemical compound CCC1=CC=C(Cl)C(C2=C(C=C(N2)C=2N=C(N)N=CC=2)C(N)=O)=C1 WIVPUMFEYLUDQN-UHFFFAOYSA-N 0.000 claims 1
- GVBXPDOSTATPIL-UHFFFAOYSA-N 5-(2-aminopyrimidin-4-yl)-2-(2-chloro-5-fluorophenyl)-1h-pyrrole-3-carboxamide Chemical compound NC(=O)C=1C=C(C=2N=C(N)N=CC=2)NC=1C1=CC(F)=CC=C1Cl GVBXPDOSTATPIL-UHFFFAOYSA-N 0.000 claims 1
- MEUXPZAVSXUFCT-UHFFFAOYSA-N 5-(2-aminopyrimidin-4-yl)-2-(2-chloro-5-methoxyphenyl)-1h-pyrrole-3-carboxamide Chemical compound COC1=CC=C(Cl)C(C2=C(C=C(N2)C=2N=C(N)N=CC=2)C(N)=O)=C1 MEUXPZAVSXUFCT-UHFFFAOYSA-N 0.000 claims 1
- MDONDWLCISBSBA-UHFFFAOYSA-N 5-(2-aminopyrimidin-4-yl)-2-(2-chloro-5-methylphenyl)-1h-pyrrole-3-carboxamide Chemical compound CC1=CC=C(Cl)C(C2=C(C=C(N2)C=2N=C(N)N=CC=2)C(N)=O)=C1 MDONDWLCISBSBA-UHFFFAOYSA-N 0.000 claims 1
- TVROLMXIPBCPIH-UHFFFAOYSA-N 5-(2-aminopyrimidin-4-yl)-2-(2-fluoro-5-methylphenyl)-1h-pyrrole-3-carboxamide Chemical compound CC1=CC=C(F)C(C2=C(C=C(N2)C=2N=C(N)N=CC=2)C(N)=O)=C1 TVROLMXIPBCPIH-UHFFFAOYSA-N 0.000 claims 1
- WYZSMYOLNHLHHE-UHFFFAOYSA-N 5-(2-aminopyrimidin-4-yl)-2-(5-bromo-2-fluorophenyl)-1h-pyrrole-3-carboxamide Chemical compound NC(=O)C=1C=C(C=2N=C(N)N=CC=2)NC=1C1=CC(Br)=CC=C1F WYZSMYOLNHLHHE-UHFFFAOYSA-N 0.000 claims 1
- ZTRQFNINWJXNEQ-UHFFFAOYSA-N 5-(2-aminopyrimidin-4-yl)-2-(5-bromo-2-methoxyphenyl)-1h-pyrrole-3-carboxamide Chemical compound COC1=CC=C(Br)C=C1C1=C(C(N)=O)C=C(C=2N=C(N)N=CC=2)N1 ZTRQFNINWJXNEQ-UHFFFAOYSA-N 0.000 claims 1
- WQFWOIDYTKRNCW-UHFFFAOYSA-N 5-(2-aminopyrimidin-4-yl)-2-(5-chloro-2-ethylphenyl)-1-methylpyrrole-3-carboxamide Chemical compound CCC1=CC=C(Cl)C=C1C(N1C)=C(C(N)=O)C=C1C1=CC=NC(N)=N1 WQFWOIDYTKRNCW-UHFFFAOYSA-N 0.000 claims 1
- GJWYRBQDZYWGDV-UHFFFAOYSA-N 5-(2-aminopyrimidin-4-yl)-2-(5-chloro-2-ethylphenyl)-1h-pyrrole-3-carboxamide Chemical compound CCC1=CC=C(Cl)C=C1C1=C(C(N)=O)C=C(C=2N=C(N)N=CC=2)N1 GJWYRBQDZYWGDV-UHFFFAOYSA-N 0.000 claims 1
- CUQICKMLWKMIKB-UHFFFAOYSA-N 5-(2-aminopyrimidin-4-yl)-2-(5-chloro-2-ethylphenyl)-n,n-dimethyl-1h-pyrrole-3-carboxamide Chemical compound CCC1=CC=C(Cl)C=C1C1=C(C(=O)N(C)C)C=C(C=2N=C(N)N=CC=2)N1 CUQICKMLWKMIKB-UHFFFAOYSA-N 0.000 claims 1
- GJXWIZZAJFWIMF-UHFFFAOYSA-N 5-(2-aminopyrimidin-4-yl)-2-(5-chloro-2-ethylphenyl)-n-(2-hydroxyethyl)-1h-pyrrole-3-carboxamide Chemical compound CCC1=CC=C(Cl)C=C1C1=C(C(=O)NCCO)C=C(C=2N=C(N)N=CC=2)N1 GJXWIZZAJFWIMF-UHFFFAOYSA-N 0.000 claims 1
- VKIAXIXFWORXFB-UHFFFAOYSA-N 5-(2-aminopyrimidin-4-yl)-2-(5-chloro-2-ethylphenyl)-n-methyl-1h-pyrrole-3-carboxamide Chemical compound CCC1=CC=C(Cl)C=C1C1=C(C(=O)NC)C=C(C=2N=C(N)N=CC=2)N1 VKIAXIXFWORXFB-UHFFFAOYSA-N 0.000 claims 1
- QLJKFALYDRKAFW-UHFFFAOYSA-N 5-(2-aminopyrimidin-4-yl)-2-(5-chloro-2-fluorophenyl)-1h-pyrrole-3-carboxamide Chemical compound NC(=O)C=1C=C(C=2N=C(N)N=CC=2)NC=1C1=CC(Cl)=CC=C1F QLJKFALYDRKAFW-UHFFFAOYSA-N 0.000 claims 1
- XOLXUIBKIXHODU-UHFFFAOYSA-N 5-(2-aminopyrimidin-4-yl)-2-(5-chloro-2-hydroxyphenyl)-1H-pyrrole-3-carboxamide Chemical compound NC(=O)C=1C=C(C=2N=C(N)N=CC=2)NC=1C1=CC(Cl)=CC=C1O XOLXUIBKIXHODU-UHFFFAOYSA-N 0.000 claims 1
- ABUHZFPSYFNGPG-UHFFFAOYSA-N 5-(2-aminopyrimidin-4-yl)-2-(5-chloro-2-methoxyphenyl)-1h-pyrrole-3-carboxamide Chemical compound COC1=CC=C(Cl)C=C1C1=C(C(N)=O)C=C(C=2N=C(N)N=CC=2)N1 ABUHZFPSYFNGPG-UHFFFAOYSA-N 0.000 claims 1
- VUTRRZOGGHDIPB-UHFFFAOYSA-N 5-(2-aminopyrimidin-4-yl)-2-(5-chloro-2-methylphenyl)-1-(2,2,2-trifluoroethyl)pyrrole-3-carboxamide Chemical compound CC1=CC=C(Cl)C=C1C(N1CC(F)(F)F)=C(C(N)=O)C=C1C1=CC=NC(N)=N1 VUTRRZOGGHDIPB-UHFFFAOYSA-N 0.000 claims 1
- JOEGVALMDOEYRU-UHFFFAOYSA-N 5-(2-aminopyrimidin-4-yl)-2-(5-chloro-2-methylphenyl)-1-(2-hydroxyethyl)pyrrole-3-carboxamide Chemical compound CC1=CC=C(Cl)C=C1C(N1CCO)=C(C(N)=O)C=C1C1=CC=NC(N)=N1 JOEGVALMDOEYRU-UHFFFAOYSA-N 0.000 claims 1
- GPSCMUMAFNLGBT-UHFFFAOYSA-N 5-(2-aminopyrimidin-4-yl)-2-(5-chloro-2-methylphenyl)-1-ethylpyrrole-3-carboxamide Chemical compound CCN1C(C=2N=C(N)N=CC=2)=CC(C(N)=O)=C1C1=CC(Cl)=CC=C1C GPSCMUMAFNLGBT-UHFFFAOYSA-N 0.000 claims 1
- QMGFZXHYEOADBG-UHFFFAOYSA-N 5-(2-aminopyrimidin-4-yl)-2-(5-chloro-2-methylphenyl)-1-methylpyrrole-3-carboxamide Chemical compound CC1=CC=C(Cl)C=C1C(N1C)=C(C(N)=O)C=C1C1=CC=NC(N)=N1 QMGFZXHYEOADBG-UHFFFAOYSA-N 0.000 claims 1
- QIHLJTBBSVIFSD-UHFFFAOYSA-N 5-(2-aminopyrimidin-4-yl)-2-(5-chloro-2-methylphenyl)-n,n-dimethyl-1h-pyrrole-3-carboxamide Chemical compound CN(C)C(=O)C=1C=C(C=2N=C(N)N=CC=2)NC=1C1=CC(Cl)=CC=C1C QIHLJTBBSVIFSD-UHFFFAOYSA-N 0.000 claims 1
- WNZGPMKWLNIIEW-UHFFFAOYSA-N 5-(2-aminopyrimidin-4-yl)-2-(5-chloro-2-methylphenyl)-n-(1-methylpiperidin-4-yl)-1h-pyrrole-3-carboxamide Chemical compound C1CN(C)CCC1NC(=O)C1=C(C=2C(=CC=C(Cl)C=2)C)NC(C=2N=C(N)N=CC=2)=C1 WNZGPMKWLNIIEW-UHFFFAOYSA-N 0.000 claims 1
- ZFZZFNFVBXBXJG-UHFFFAOYSA-N 5-(2-aminopyrimidin-4-yl)-2-(5-chloro-2-methylphenyl)-n-(2,2-dimethylpropyl)-1h-pyrrole-3-carboxamide Chemical compound CC1=CC=C(Cl)C=C1C1=C(C(=O)NCC(C)(C)C)C=C(C=2N=C(N)N=CC=2)N1 ZFZZFNFVBXBXJG-UHFFFAOYSA-N 0.000 claims 1
- PNYZVAIGFZQRDS-UHFFFAOYSA-N 5-(2-aminopyrimidin-4-yl)-2-(5-chloro-2-methylphenyl)-n-(2-fluoroethyl)-1h-pyrrole-3-carboxamide Chemical compound CC1=CC=C(Cl)C=C1C1=C(C(=O)NCCF)C=C(C=2N=C(N)N=CC=2)N1 PNYZVAIGFZQRDS-UHFFFAOYSA-N 0.000 claims 1
- ZXKPOMXJHLXQKX-UHFFFAOYSA-N 5-(2-aminopyrimidin-4-yl)-2-(5-chloro-2-methylphenyl)-n-(2-hydroxyethyl)-1h-pyrrole-3-carboxamide Chemical compound CC1=CC=C(Cl)C=C1C1=C(C(=O)NCCO)C=C(C=2N=C(N)N=CC=2)N1 ZXKPOMXJHLXQKX-UHFFFAOYSA-N 0.000 claims 1
- OSTUOGNGBFCXNG-UHFFFAOYSA-N 5-(2-aminopyrimidin-4-yl)-2-(5-chloro-2-methylphenyl)-n-(2-methoxyethyl)-1h-pyrrole-3-carboxamide Chemical compound COCCNC(=O)C=1C=C(C=2N=C(N)N=CC=2)NC=1C1=CC(Cl)=CC=C1C OSTUOGNGBFCXNG-UHFFFAOYSA-N 0.000 claims 1
- JCPLJMMYNOZMBU-UHFFFAOYSA-N 5-(2-aminopyrimidin-4-yl)-2-(5-chloro-2-methylphenyl)-n-(2-methylpropyl)-1h-pyrrole-3-carboxamide Chemical compound CC(C)CNC(=O)C=1C=C(C=2N=C(N)N=CC=2)NC=1C1=CC(Cl)=CC=C1C JCPLJMMYNOZMBU-UHFFFAOYSA-N 0.000 claims 1
- IKOXHEDMAJQABQ-UHFFFAOYSA-N 5-(2-aminopyrimidin-4-yl)-2-(5-chloro-2-methylphenyl)-n-(2-piperidin-1-ylethyl)-1h-pyrrole-3-carboxamide Chemical compound CC1=CC=C(Cl)C=C1C1=C(C(=O)NCCN2CCCCC2)C=C(C=2N=C(N)N=CC=2)N1 IKOXHEDMAJQABQ-UHFFFAOYSA-N 0.000 claims 1
- JXROIQYBLXITAR-UHFFFAOYSA-N 5-(2-aminopyrimidin-4-yl)-2-(5-chloro-2-methylphenyl)-n-(3-hydroxypropyl)-1h-pyrrole-3-carboxamide Chemical compound CC1=CC=C(Cl)C=C1C1=C(C(=O)NCCCO)C=C(C=2N=C(N)N=CC=2)N1 JXROIQYBLXITAR-UHFFFAOYSA-N 0.000 claims 1
- VVCSHJRAAVFYAE-UHFFFAOYSA-N 5-(2-aminopyrimidin-4-yl)-2-(5-chloro-2-methylphenyl)-n-(furan-2-ylmethyl)-1h-pyrrole-3-carboxamide Chemical compound CC1=CC=C(Cl)C=C1C1=C(C(=O)NCC=2OC=CC=2)C=C(C=2N=C(N)N=CC=2)N1 VVCSHJRAAVFYAE-UHFFFAOYSA-N 0.000 claims 1
- NKTCWCPLTZQABU-UHFFFAOYSA-N 5-(2-aminopyrimidin-4-yl)-2-(5-chloro-2-methylphenyl)-n-[2-(methylamino)ethyl]-1h-pyrrole-3-carboxamide Chemical compound CNCCNC(=O)C=1C=C(C=2N=C(N)N=CC=2)NC=1C1=CC(Cl)=CC=C1C NKTCWCPLTZQABU-UHFFFAOYSA-N 0.000 claims 1
- RMCUEMSKMGVKOG-UHFFFAOYSA-N 5-(2-aminopyrimidin-4-yl)-2-(5-chloro-2-methylphenyl)-n-ethyl-1h-pyrrole-3-carboxamide Chemical compound CCNC(=O)C=1C=C(C=2N=C(N)N=CC=2)NC=1C1=CC(Cl)=CC=C1C RMCUEMSKMGVKOG-UHFFFAOYSA-N 0.000 claims 1
- BFOWVKRAGHVYJA-UHFFFAOYSA-N 5-(2-aminopyrimidin-4-yl)-2-(5-chloro-2-methylphenyl)-n-methyl-1h-pyrrole-3-carboxamide Chemical compound CNC(=O)C=1C=C(C=2N=C(N)N=CC=2)NC=1C1=CC(Cl)=CC=C1C BFOWVKRAGHVYJA-UHFFFAOYSA-N 0.000 claims 1
- AOBREUVPEFZVPG-UHFFFAOYSA-N 5-(2-aminopyrimidin-4-yl)-2-(5-chloro-2-methylphenyl)-n-phenyl-1h-pyrrole-3-carboxamide Chemical compound CC1=CC=C(Cl)C=C1C1=C(C(=O)NC=2C=CC=CC=2)C=C(C=2N=C(N)N=CC=2)N1 AOBREUVPEFZVPG-UHFFFAOYSA-N 0.000 claims 1
- KMWLMMWKLAILOY-UHFFFAOYSA-N 5-(2-aminopyrimidin-4-yl)-2-(5-chloro-2-propan-2-ylphenyl)-1h-pyrrole-3-carboxamide Chemical compound CC(C)C1=CC=C(Cl)C=C1C1=C(C(N)=O)C=C(C=2N=C(N)N=CC=2)N1 KMWLMMWKLAILOY-UHFFFAOYSA-N 0.000 claims 1
- LIJKTJFYXDIILH-UHFFFAOYSA-N 5-(2-aminopyrimidin-4-yl)-2-(5-cyano-2-methylphenyl)-1h-pyrrole-3-carboxamide Chemical compound CC1=CC=C(C#N)C=C1C1=C(C(N)=O)C=C(C=2N=C(N)N=CC=2)N1 LIJKTJFYXDIILH-UHFFFAOYSA-N 0.000 claims 1
- SUQQWUFPIFVFCZ-UHFFFAOYSA-N 5-(2-aminopyrimidin-4-yl)-2-(5-fluoro-2-methylphenyl)-1h-pyrrole-3-carboxamide Chemical compound CC1=CC=C(F)C=C1C1=C(C(N)=O)C=C(C=2N=C(N)N=CC=2)N1 SUQQWUFPIFVFCZ-UHFFFAOYSA-N 0.000 claims 1
- MOMYBDKTKLWNMV-UHFFFAOYSA-N 5-(2-aminopyrimidin-4-yl)-2-[2,5-bis(trifluoromethyl)phenyl]-1h-pyrrole-3-carboxamide Chemical compound NC(=O)C=1C=C(C=2N=C(N)N=CC=2)NC=1C1=CC(C(F)(F)F)=CC=C1C(F)(F)F MOMYBDKTKLWNMV-UHFFFAOYSA-N 0.000 claims 1
- LNLCSFSRFGZNPP-UHFFFAOYSA-N 5-(2-aminopyrimidin-4-yl)-2-[2-chloro-5-(hydroxymethyl)phenyl]-1h-pyrrole-3-carboxamide Chemical compound NC(=O)C=1C=C(C=2N=C(N)N=CC=2)NC=1C1=CC(CO)=CC=C1Cl LNLCSFSRFGZNPP-UHFFFAOYSA-N 0.000 claims 1
- IVXPIHCWBHLFEM-UHFFFAOYSA-N 5-(2-aminopyrimidin-4-yl)-2-[2-chloro-5-(trifluoromethoxy)phenyl]-1h-pyrrole-3-carboxamide Chemical compound NC(=O)C=1C=C(C=2N=C(N)N=CC=2)NC=1C1=CC(OC(F)(F)F)=CC=C1Cl IVXPIHCWBHLFEM-UHFFFAOYSA-N 0.000 claims 1
- CZUQYAXYBOEHCY-UHFFFAOYSA-N 5-(2-aminopyrimidin-4-yl)-2-[2-chloro-5-(trifluoromethyl)phenyl]-1h-pyrrole-3-carboxamide Chemical compound NC(=O)C=1C=C(C=2N=C(N)N=CC=2)NC=1C1=CC(C(F)(F)F)=CC=C1Cl CZUQYAXYBOEHCY-UHFFFAOYSA-N 0.000 claims 1
- BRIIWIAIUSRCEY-UHFFFAOYSA-N 5-(2-aminopyrimidin-4-yl)-2-[2-chloro-5-(trifluoromethyl)phenyl]-n-methyl-1h-pyrrole-3-carboxamide Chemical compound CNC(=O)C=1C=C(C=2N=C(N)N=CC=2)NC=1C1=CC(C(F)(F)F)=CC=C1Cl BRIIWIAIUSRCEY-UHFFFAOYSA-N 0.000 claims 1
- DBTPIYXNTFESLE-UHFFFAOYSA-N 5-(2-aminopyrimidin-4-yl)-2-[2-ethyl-5-(trifluoromethyl)phenyl]-1h-pyrrole-3-carboxamide Chemical compound CCC1=CC=C(C(F)(F)F)C=C1C1=C(C(N)=O)C=C(C=2N=C(N)N=CC=2)N1 DBTPIYXNTFESLE-UHFFFAOYSA-N 0.000 claims 1
- JTCAMVAHTMGGBT-UHFFFAOYSA-N 5-(2-aminopyrimidin-4-yl)-2-[2-ethyl-5-(trifluoromethyl)phenyl]-n-methyl-1h-pyrrole-3-carboxamide Chemical compound CCC1=CC=C(C(F)(F)F)C=C1C1=C(C(=O)NC)C=C(C=2N=C(N)N=CC=2)N1 JTCAMVAHTMGGBT-UHFFFAOYSA-N 0.000 claims 1
- BOOUSDCCWQVKID-UHFFFAOYSA-N 5-(2-aminopyrimidin-4-yl)-2-[2-methyl-5-(trifluoromethyl)phenyl]-1h-pyrrole-3-carboxamide Chemical compound CC1=CC=C(C(F)(F)F)C=C1C1=C(C(N)=O)C=C(C=2N=C(N)N=CC=2)N1 BOOUSDCCWQVKID-UHFFFAOYSA-N 0.000 claims 1
- FWVOSTMZZQGURQ-UHFFFAOYSA-N 5-(2-aminopyrimidin-4-yl)-2-[5-chloro-2-(trifluoromethyl)phenyl]-1h-pyrrole-3-carboxamide Chemical compound NC(=O)C=1C=C(C=2N=C(N)N=CC=2)NC=1C1=CC(Cl)=CC=C1C(F)(F)F FWVOSTMZZQGURQ-UHFFFAOYSA-N 0.000 claims 1
- STEACKYPSKNGJJ-UHFFFAOYSA-N 5-(2-aminopyrimidin-4-yl)-n-benzyl-2-(5-chloro-2-methylphenyl)-1h-pyrrole-3-carboxamide Chemical compound CC1=CC=C(Cl)C=C1C1=C(C(=O)NCC=2C=CC=CC=2)C=C(C=2N=C(N)N=CC=2)N1 STEACKYPSKNGJJ-UHFFFAOYSA-N 0.000 claims 1
- ZDACAYMVFNLNGY-UHFFFAOYSA-N 5-(2-aminopyrimidin-4-yl)-n-methyl-2-[2-methyl-5-(trifluoromethyl)phenyl]-1h-pyrrole-3-carboxamide Chemical compound CNC(=O)C=1C=C(C=2N=C(N)N=CC=2)NC=1C1=CC(C(F)(F)F)=CC=C1C ZDACAYMVFNLNGY-UHFFFAOYSA-N 0.000 claims 1
- ONZWLXUGPDQTJM-UHFFFAOYSA-N ClC=1C=CC(=C(C=1)C=1NC(=CC=1C(=O)N)C1=CC(=NC=C1)NC)C Chemical compound ClC=1C=CC(=C(C=1)C=1NC(=CC=1C(=O)N)C1=CC(=NC=C1)NC)C ONZWLXUGPDQTJM-UHFFFAOYSA-N 0.000 claims 1
- 101000997835 Homo sapiens Tyrosine-protein kinase JAK1 Proteins 0.000 claims 1
- 101000997832 Homo sapiens Tyrosine-protein kinase JAK2 Proteins 0.000 claims 1
- 101000934996 Homo sapiens Tyrosine-protein kinase JAK3 Proteins 0.000 claims 1
- 239000002841 Lewis acid Substances 0.000 claims 1
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 claims 1
- 102100033438 Tyrosine-protein kinase JAK1 Human genes 0.000 claims 1
- 102100033444 Tyrosine-protein kinase JAK2 Human genes 0.000 claims 1
- 102100025387 Tyrosine-protein kinase JAK3 Human genes 0.000 claims 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 claims 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 claims 1
- 239000012346 acetyl chloride Substances 0.000 claims 1
- 125000002777 acetyl group Chemical class [H]C([H])([H])C(*)=O 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 150000001409 amidines Chemical class 0.000 claims 1
- ZRALSGWEFCBTJO-UHFFFAOYSA-N anhydrous guanidine Natural products NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 claims 1
- 230000001093 anti-cancer Effects 0.000 claims 1
- 238000011319 anticancer therapy Methods 0.000 claims 1
- 150000001543 aryl boronic acids Chemical class 0.000 claims 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 150000002081 enamines Chemical class 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 150000002357 guanidines Chemical class 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 125000004415 heterocyclylalkyl group Chemical group 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- 150000007517 lewis acids Chemical class 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- RCEHZMJNOKHNLP-UHFFFAOYSA-N n-(2-aminoethyl)-5-(2-aminopyrimidin-4-yl)-2-(5-chloro-2-methylphenyl)-1h-pyrrole-3-carboxamide Chemical compound CC1=CC=C(Cl)C=C1C1=C(C(=O)NCCN)C=C(C=2N=C(N)N=CC=2)N1 RCEHZMJNOKHNLP-UHFFFAOYSA-N 0.000 claims 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 125000003107 substituted aryl group Chemical group 0.000 claims 1
- 239000011701 zinc Substances 0.000 claims 1
- 229910052725 zinc Inorganic materials 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11162960.6 | 2011-04-19 | ||
| EP11162960 | 2011-04-19 | ||
| PCT/EP2012/056266 WO2012143248A1 (en) | 2011-04-19 | 2012-04-05 | Substituted pyrimidinyl-pyrroles active as kinase inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014516360A JP2014516360A (ja) | 2014-07-10 |
| JP2014516360A5 true JP2014516360A5 (enExample) | 2015-05-21 |
| JP5970537B2 JP5970537B2 (ja) | 2016-08-17 |
Family
ID=45928917
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014505570A Expired - Fee Related JP5970537B2 (ja) | 2011-04-19 | 2012-04-05 | キナーゼ阻害薬として活性な置換ピリミジニル−ピロール |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US9283224B2 (enExample) |
| EP (1) | EP2699564B1 (enExample) |
| JP (1) | JP5970537B2 (enExample) |
| CN (1) | CN103502241B (enExample) |
| BR (1) | BR112013026137B1 (enExample) |
| ES (1) | ES2616458T3 (enExample) |
| RU (1) | RU2621732C2 (enExample) |
| WO (1) | WO2012143248A1 (enExample) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR077468A1 (es) | 2009-07-09 | 2011-08-31 | Array Biopharma Inc | Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa |
| BR112014024064B8 (pt) | 2012-03-30 | 2022-10-11 | Dow Agrosciences Llc | Métodos para preparação de 3-substituída-6-triflúormetil piridinas e para formação de 3-halo-6-triflúormetil piridina |
| WO2015040243A2 (en) * | 2013-09-23 | 2015-03-26 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and compositions for targeting tumor microenvironment and for preventing metastasis |
| JP6816100B2 (ja) | 2015-07-16 | 2021-01-20 | アレイ バイオファーマ、インコーポレイテッド | ＲＥＴキナーゼ阻害物質としての置換ピラゾロ［１，５−ａ］ピリジン化合物 |
| US10724102B2 (en) | 2015-10-26 | 2020-07-28 | Loxo Oncology, Inc. | Point mutations in TRK inhibitor-resistant cancer and methods relating to the same |
| SG11201808559PA (en) | 2016-04-04 | 2018-10-30 | Loxo Oncology Inc | Liquid formulations of (s)-n-(5-((r)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide |
| US10045991B2 (en) | 2016-04-04 | 2018-08-14 | Loxo Oncology, Inc. | Methods of treating pediatric cancers |
| PL3439663T3 (pl) | 2016-04-04 | 2024-11-18 | Loxo Oncology, Inc. | Sposoby leczenia nowotworów wieku dziecięcego |
| FI3800189T3 (fi) | 2016-05-18 | 2023-07-31 | Loxo Oncology Inc | (s)-n-(5-((r)-2-(2,5-difluorifenyyli)pyrrolidin-1-yyli)pyratsolo[1,5-a]pyrimidin-3-yyli)-3-hydroksipyrrolidiini-1-karboksamidin valmistaminen |
| TWI704148B (zh) | 2016-10-10 | 2020-09-11 | 美商亞雷生物製藥股份有限公司 | 作為ｒｅｔ激酶抑制劑之經取代吡唑并[1,5-a]吡啶化合物 |
| JOP20190077A1 (ar) | 2016-10-10 | 2019-04-09 | Array Biopharma Inc | مركبات بيرازولو [1، 5-a]بيريدين بها استبدال كمثبطات كيناز ret |
| JOP20190092A1 (ar) | 2016-10-26 | 2019-04-25 | Array Biopharma Inc | عملية لتحضير مركبات بيرازولو[1، 5-a]بيريميدين وأملاح منها |
| WO2018136663A1 (en) | 2017-01-18 | 2018-07-26 | Array Biopharma, Inc. | Ret inhibitors |
| ES2948194T3 (es) | 2017-01-18 | 2023-09-01 | Array Biopharma Inc | Compuestos de pirazolo[1,5-a]pirazina sustituida como inhibidores de la cinasa RET |
| JOP20190213A1 (ar) | 2017-03-16 | 2019-09-16 | Array Biopharma Inc | مركبات حلقية ضخمة كمثبطات لكيناز ros1 |
| GB201706806D0 (en) | 2017-04-28 | 2017-06-14 | Sentinel Oncology Ltd | Pharmaceutical compounds |
| TWI812649B (zh) | 2017-10-10 | 2023-08-21 | 美商絡速藥業公司 | 6-(2-羥基-2-甲基丙氧基)-4-(6-(6-((6-甲氧基吡啶-3-基)甲基)-3,6-二氮雜雙環[3.1.1]庚-3-基)吡啶-3-基)吡唑并[1,5-a]吡啶-3-甲腈之調配物 |
| TWI791053B (zh) | 2017-10-10 | 2023-02-01 | 美商亞雷生物製藥股份有限公司 | 6-(2-羥基-2-甲基丙氧基)-4-(6-(6-((6-甲氧基吡啶-3-基)甲基)-3,6-二氮雜雙環[3.1.1]庚-3-基)吡啶-3-基)吡唑并[1,5-a]吡啶-3-甲腈之結晶形式及其醫藥組合物 |
| CN107970438B (zh) * | 2017-11-28 | 2021-08-13 | 镇江市中西医结合医院（镇江市第二人民医院） | 一种神经再生凝胶及其制备方法和应用 |
| TW201938169A (zh) | 2018-01-18 | 2019-10-01 | 美商亞雷生物製藥股份有限公司 | 作為RET激酶抑制劑之經取代吡唑并[3,4-d]嘧啶化合物 |
| US11603374B2 (en) | 2018-01-18 | 2023-03-14 | Array Biopharma Inc. | Substituted pyrrolo[2,3-d]pyrimidines compounds as ret kinase inhibitors |
| JP6997876B2 (ja) | 2018-01-18 | 2022-02-04 | アレイ バイオファーマ インコーポレイテッド | Ｒｅｔキナーゼ阻害剤としての置換ピラゾリル［４，３－ｃ］ピリジン化合物 |
| CA3224985A1 (en) | 2018-07-31 | 2020-02-06 | Loxo Oncology, Inc. | Spray-dried dispersions, formulations, and polymorphs of (s)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-(1,1,1-trifluoropropan-2-yl)-1h-pyrazole-4-carboxamide |
| CA3111984A1 (en) | 2018-09-10 | 2020-03-19 | Array Biopharma Inc. | Fused heterocyclic compounds as ret kinase inhibitors |
| CN113490666A (zh) | 2018-12-19 | 2021-10-08 | 奥瑞生物药品公司 | 作为fgfr酪氨酸激酶的抑制剂的取代的吡唑并[1,5-a]吡啶化合物 |
| EP3898615A1 (en) | 2018-12-19 | 2021-10-27 | Array Biopharma, Inc. | 7-((3,5-dimethoxyphenyl)amino)quinoxaline derivatives as fgfr inhibitors for treating cancer |
| US20220372135A1 (en) | 2019-09-27 | 2022-11-24 | Disc Medicine, Inc. | Methods for treating myelofibrosis and related conditions |
| EP4069369A4 (en) | 2019-12-06 | 2024-02-14 | Schrödinger, Inc. | CYCLIC COMPOUNDS AND METHODS OF USE THEREOF |
| PH12022551523A1 (en) | 2019-12-27 | 2024-01-29 | SchraDinger Inc | Cyclic compounds and methods of using same |
| IL297437A (en) | 2020-05-13 | 2022-12-01 | Disc Medicine Inc | Anti-hemojuvelin (hjv) antibodies for treating myelofibrosis |
| CN116490507A (zh) | 2020-09-10 | 2023-07-25 | 薛定谔公司 | 用于治疗癌症的杂环包缩合cdc7激酶抑制剂 |
| US20240285621A1 (en) * | 2020-09-23 | 2024-08-29 | Nerviano Medical Sciences S.R.L. | Pyrazolyl-pyrimidine derivatives as kinase inhibitors |
| JP2024505890A (ja) | 2021-01-26 | 2024-02-08 | シュレーディンガー， インコーポレイテッド | がん、自己免疫及び炎症性障害の治療に有用な三環式化合物 |
| TW202300150A (zh) | 2021-03-18 | 2023-01-01 | 美商薛定諤公司 | 環狀化合物及其使用方法 |
| WO2025059027A1 (en) | 2023-09-11 | 2025-03-20 | Schrödinger, Inc. | Cyclopenta[e]pyrazolo[1,5-a]pyrimidine derivatives as malt1 inhibitors |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7419984B2 (en) * | 2002-10-17 | 2008-09-02 | Cell Therapeutics, Inc. | Pyrimidines and uses thereof |
| TW200526626A (en) * | 2003-09-13 | 2005-08-16 | Astrazeneca Ab | Chemical compounds |
| CN101421250A (zh) * | 2006-01-30 | 2009-04-29 | 埃克塞里艾克西斯公司 | 作为jak-2调节剂的4-芳基-2-氨基-嘧啶或4-芳基-2-氨基烷基-嘧啶及包含它们的药物组合物 |
| UA94097C2 (ru) * | 2006-03-27 | 2011-04-11 | НЕРВИАНО МЕДИКАЛ САЙЕНСИЗ С.р.л. | Пиридил- и пиримидинилзамещенные производной пиррола, тиофена и фурана как ингибиторы киназ |
| WO2009046416A1 (en) * | 2007-10-05 | 2009-04-09 | Targegen Inc. | Anilinopyrimidines as jak kinase inhibitors |
| TWI426074B (zh) * | 2008-04-30 | 2014-02-11 | Nerviano Medical Sciences Srl | ５－（２－胺基－嘧啶－４－基）－２－芳基－１ｈ－吡咯－３－羧醯胺之製造方法 |
| WO2010108921A1 (en) * | 2009-03-27 | 2010-09-30 | Nerviano Medical Sciences S.R.L. | N-aryl-2-(2-arylaminopyrimidin-4-yl)pyrrol-4-carboxamide derivatives as mps1 kinase inhibitors |
| JP5715146B2 (ja) * | 2009-11-04 | 2015-05-07 | ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ | ５−（２−アミノ−ピリミジン−４−イル）−２−アリール−１ｈ−ピロール−３−カルボキサミドの調製方法 |
| EP2499128B1 (en) * | 2009-11-11 | 2015-06-03 | Nerviano Medical Sciences S.r.l. | Crystalline cdc7 inhibitor salts |
| JP6016915B2 (ja) * | 2011-07-28 | 2016-10-26 | ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ | キナーゼ阻害剤として活性なアルキニル置換ピリミジニルピロール |
-
2012
- 2012-04-05 EP EP12711904.8A patent/EP2699564B1/en active Active
- 2012-04-05 RU RU2013151174A patent/RU2621732C2/ru active
- 2012-04-05 US US14/112,559 patent/US9283224B2/en active Active
- 2012-04-05 JP JP2014505570A patent/JP5970537B2/ja not_active Expired - Fee Related
- 2012-04-05 WO PCT/EP2012/056266 patent/WO2012143248A1/en not_active Ceased
- 2012-04-05 ES ES12711904.8T patent/ES2616458T3/es active Active
- 2012-04-05 BR BR112013026137-4A patent/BR112013026137B1/pt not_active IP Right Cessation
- 2012-04-05 CN CN201280018834.4A patent/CN103502241B/zh not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014516360A5 (enExample) | ||
| RU2013151174A (ru) | Замещенные пиримидинилпирролы, активные в качестве ингибиторов киназы | |
| KR101502959B1 (ko) | 5원환 헤테로환 유도체 및 그 의약 용도 | |
| RU2015106787A (ru) | Замещенные пирролы, активные в качестве ингибиторов киназ | |
| PE20110062A1 (es) | N-(3-(3,5-dimetoxifenetil)-1h-pirazol-5-il)-4-(3,4-dimetilpiperazin-1-il)benzamida y sales del mismo | |
| JP2011509949A5 (enExample) | ||
| RU2014145856A (ru) | Азотсодержащее гетероциклическое соединение или его соль | |
| JP2014511869A5 (enExample) | ||
| RS60312B1 (sr) | Jedinjenja indol karboksamida korisna kao inhibitori kinaze | |
| JP2016053042A5 (enExample) | ||
| JPWO2020085493A1 (ja) | 新規なインダゾール化合物又はその塩 | |
| JP2013506715A5 (enExample) | ||
| CA2565813A1 (en) | Substituted methyl aryl or heteroaryl amide compounds | |
| JP2014506599A5 (enExample) | ||
| JP2014521653A5 (enExample) | ||
| JP2014506907A5 (enExample) | ||
| NZ603364A (en) | Inhibitors of arginase and their therapeutic applications | |
| JP2008509187A5 (enExample) | ||
| JP2011509309A5 (enExample) | ||
| JP2013532668A5 (enExample) | ||
| JP2012507525A5 (enExample) | ||
| JP2015535847A5 (enExample) | ||
| RU2011140869A (ru) | Пиперазиновое соединение, ингибирующее простагландин-d-синтазу | |
| JP2016540811A5 (enExample) | ||
| JP2013542267A5 (enExample) |